Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genolimbs is an emerging biotechnology and medical device company focused on the development of next-generation bionic limbs and neural interface technologies. The company aims to bridge the gap between human biology and robotics by creating prosthetics that offer sensory feedback and intuitive control through direct neural integration. Their research focuses on enhancing the quality of life for individuals with limb loss or paralysis by restoring natural movement and tactile sensation. Genolimbs is currently in the early stages of developing its core platform, which leverages advanced materials and signal processing to improve the interface between peripheral nerves and mechanical components.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genolimbs.